Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


Articles published in Acta Haematol

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    April 2019
  1. FELD J, Arnason J, O Apos Brien K, Nahas M, et al
    Hot and Cold: A Concurrent Warm and Cold Autoimmune Hemolytic Anemia in B-cell Prolymphocytic Leukemia.
    Acta Haematol. 2019;141:222-224.
    PubMed     Text format    


    February 2019
  2. LI Z, Liu Y, Wang Q, Chen L, et al
    Autologous Stem Cell Transplantation Is a Viable Postremission Therapy for Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission in the Absence of a Matched Identical Sibling: A Meta-Analysis.
    Acta Haematol. 2019;141:164-175.
    PubMed     Text format     Abstract available


  3. TAHARA K, Koiso H, Osaki YH, Sekigami T, et al
    Malignancy-Associated Hypercalcemia Related with Receptor Activator of NF-kappaB Ligand (RANKL) Expression in T-Cell Acute Lymphoblastic Leukemia.
    Acta Haematol. 2019;141:135-137.
    PubMed     Text format    


    December 2018
  4. WANG L, Xu J, Tian X, Lv T, et al
    Analysis of Efficacy and Prognostic Factors of CLAG Treatment in Chinese Patients with Refractory or Relapsed Acute Myeloid Leukemia.
    Acta Haematol. 2018;141:43-53.
    PubMed     Text format     Abstract available


    November 2018
  5. ABRUZZESE E, Trawinska MM, Neri B, Bondanini F, et al
    Successful Decitabine Treatment in Unfit, Elderly Patients with Acute Myeloid Leukemia following Chronic Myeloproliferative Neoplasm.
    Acta Haematol. 2018;140:231-233.
    PubMed     Text format    


    October 2018
  6. CHOTSAMPANCHAROEN T, Sripornsawan P, Duangchu S, Wongchanchailert M, et al
    Survival Outcome of Alternative Medicine Treatment for Newly Diagnosed Acute Leukemia in Children.
    Acta Haematol. 2018;140:203-208.
    PubMed     Text format     Abstract available


  7. NACHMIAS B, Shaulov A, Gatt ME, Shapira M, et al
    A Bortezomib-Based Protocol Induces a High Rate of Complete Remission with Minor Toxicity in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.
    Acta Haematol. 2018;140:209-214.
    PubMed     Text format     Abstract available


  8. JIANG L, Deng T, Wang D, Xiao Y, et al
    Elevated Serum Exosomal miR-125b Level as a Potential Marker for Poor Prognosis in Intermediate-Risk Acute Myeloid Leukemia.
    Acta Haematol. 2018;140:183-192.
    PubMed     Text format     Abstract available


    September 2018
  9. GIONA F, Santopietro M, Menna G, Putti MC, et al
    Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience.
    Acta Haematol. 2018;140:105-111.
    PubMed     Text format     Abstract available


  10. NAESENS L, Devos H, Nollet F, Michaux L, et al
    Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-MLLT10 Fusion Gene.
    Acta Haematol. 2018;140:97-104.
    PubMed     Text format     Abstract available


  11. HA M, Kim JY, Han ME, Kim GH, et al
    TMEM18: A Novel Prognostic Marker in Acute Myeloid Leukemia.
    Acta Haematol. 2018;140:71-76.
    PubMed     Text format     Abstract available


    August 2018
  12. ROZOVSKI U, Keating MJ, Estrov Z
    Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia?
    Acta Haematol. 2018;140:51-54.
    PubMed     Text format     Abstract available


  13. ABOU DALLE I, Cortes JE, Pinnamaneni P, Lamothe B, et al
    A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia.
    Acta Haematol. 2018;140:30-39.
    PubMed     Text format     Abstract available


    June 2018
  14. PARK HS, Kim DY, Choi EJ, Lee JH, et al
    Blast Percentage of Bone Marrow Aspirate on Day 14 of Induction Chemotherapy Predicts Adult Acute Lymphoblastic Leukemia Treatment Outcomes.
    Acta Haematol. 2018;139:220-227.
    PubMed     Text format     Abstract available


    March 2018
  15. SCHNEIDEWEND R, Hosking P, Brazauskas R, Peterson J, et al
    Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy.
    Acta Haematol. 2018;139:171-175.
    PubMed     Text format    


    February 2018
  16. SONG X, Peng Y, Wang X, Chen Y, et al
    Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-201
    Acta Haematol. 2018;139:115-127.
    PubMed     Text format     Abstract available


  17. BRUNNER AM
    No Mutation Left Behind: The Impact of Reporting Recurrent Genetic Abnormalities on Outcomes of Patients with Acute Myeloid Leukemia.
    Acta Haematol. 2018;139:128-130.
    PubMed     Text format    


  18. BARON BW, Thirman MJ, Giurcanu MC, Baron JM, et al
    Quercetin Therapy for Selected Patients with PIM1 Kinase-Positive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pilot Study.
    Acta Haematol. 2018;139:132-139.
    PubMed     Text format     Abstract available


  19. TANG X, Zhou J, Zhang J, Zhou LY, et al
    Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia.
    Acta Haematol. 2018;139:89-95.
    PubMed     Text format     Abstract available


    January 2018
  20. NISCOLA P, Neri B, Morino L, de Fabritiis P, et al
    Monoclonal Gammopathy Responsive to Decitabine Given for Acute Myeloid Leukemia in a Frail Patient.
    Acta Haematol. 2018;139:58-59.
    PubMed     Text format    


  21. LV H, Hu S, Lu J, Zhai Q, et al
    Precursor T-Lymphoblastic Lymphoma Associated with t(8;9)(p11.2;q33): A Case Report and Review of the Literature.
    Acta Haematol. 2018;139:176-182.
    PubMed     Text format     Abstract available


    September 2017
  22. LEADER A, Raanani P
    Switching-On Adherence in Chronic Myeloid Leukemia.
    Acta Haematol. 2017;138:138-139.
    PubMed     Text format    


  23. MAEDA Y, Okamoto A, Kawaguchi SI, Konishi A, et al
    Improved Drug Adherence in Patients with Chronic Myeloid Leukemia in the Chronic Phase by Switching to Second-Generation Tyrosine Kinase Inhibitors.
    Acta Haematol. 2017;138:140-142.
    PubMed     Text format    


  24. LIEBERMAN F, Villgran V, Normolle D, Boyiadzis M, et al
    Intracranial Hemorrhage in Patients Newly Diagnosed with Acute Myeloid Leukemia and Hyperleukocytosis.
    Acta Haematol. 2017;138:116-118.
    PubMed     Text format    


    July 2017
  25. TIMMERMANS K, Leijte GP, Kox M, Scheffer GJ, et al
    Release of Danger-Associated Molecular Patterns following Chemotherapy Does Not Induce Immunoparalysis in Leukemia Patients.
    Acta Haematol. 2017;138:39-43.
    PubMed     Text format     Abstract available


  26. ANAGNOSTOPOULOU E, Papanastasopoulou C, Papastamataki M, Kotsiou A, et al
    Serum Hyaluronic Acid Levels Are Altered in Acute Leukemia Patients: Potential Prognostic Implications.
    Acta Haematol. 2017;138:44-51.
    PubMed     Text format     Abstract available


  27. HERNANDEZ-RIVAS JA, Gonzalez-Gascon Y Marin I
    Genetic Heterogeneity in Chronic Lymphocytic Leukemia: What Can Conventional Cytogenetics Add?
    Acta Haematol. 2017;138:31-32.
    PubMed     Text format    


    June 2017
  28. CHANG H, Kuo MC, Tang TC, Lin TL, et al
    Clinical Features and Recurrence Pattern of Perianal Abscess in Patients with Acute Myeloid Leukemia.
    Acta Haematol. 2017;138:10-13.
    PubMed     Text format     Abstract available


    May 2017
  29. PETERSON JF, Shah R, Kobrinski D
    Two Distinct BCL2 Rearrangements, Each Observed in 2 Independent Subclones, Evolving from a Founder Clone with Trisomy 12 in a Unique Case of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Acta Haematol. 2017;137:237-239.
    PubMed     Text format    


    April 2017
  30. ZHAO H, Xu L, Yang Y, Shao J, et al
    Successful Management of Decitabine prior to Full-Dose Idarubicin and Cytarabine in the Treatment of Refractory/Recurrent Acute Myeloid Leukemia.
    Acta Haematol. 2017;137:195-200.
    PubMed     Text format     Abstract available


  31. LI Y, Wang CL, Din B, Yu L, et al
    Continuing Imatinib Treatment for Chronic Myeloid Leukemia Patients Who Had Serious Adverse Events at the Onset of Therapy.
    Acta Haematol. 2017;137:158-162.
    PubMed     Text format    


  32. PTACKOVA P, Petrackova M, Hindos M, Duskova M, et al
    Intracellular Cytokines Produced by Stimulated CD3+ Cells from Chronic Myeloid Leukemia Patients.
    Acta Haematol. 2017;137:148-157.
    PubMed     Text format     Abstract available


    January 2017
  33. GUREVICH-SHAPIRO A, Tzadok S, Rosenberg A, Inbal A, et al
    Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.
    Acta Haematol. 2017;137:183-190.
    PubMed     Text format     Abstract available


  34. LIANG Y, Gao J, Wu D, Li S, et al
    Long-Term Remission following Autologous Hematopoietic Cell Transplantation in a Patient with Multiple Nonleukemic Myeloid Sarcoma and a Review of the Literature.
    Acta Haematol. 2017;137:117-122.
    PubMed     Text format     Abstract available


  35. SCHNEIDEWIND L, Neumann T, Knoll F, Zimmermann K, et al
    Are the Polyomaviruses BK and JC Associated with Opportunistic Infections, Graft-versus-Host Disease, or Worse Outcomes in Adult Patients Receiving Their First Allogeneic Stem Cell Transplantation with Low-Dose Alemtuzumab?
    Acta Haematol. 2017;138:3-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: